IMR Press / FBS / Volume 14 / Issue 2 / DOI: 10.31083/j.fbs1402012
Open Access Opinion
A Possible Synergistic Herbal Solution for COVID-19
Show Less
1 Laboratory of Applied Metabolomics and Pharmacognosy (LAMP), Institute of Evolution, University of Haifa, 3498838 Haifa, Israel
*Correspondence: elansky@research.haifa.ac.il (Ephraim Shmaya Lansky)
Academic Editor: Jen-Tsung Chen
Front. Biosci. (Schol Ed) 2022, 14(2), 012; https://doi.org/10.31083/j.fbs1402012
Submitted: 1 March 2022 | Revised: 30 March 2022 | Accepted: 7 April 2022 | Published: 6 May 2022
(This article belongs to the Special Issue Recent Research on Medicinal Plants)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

The COVID-19 pandemic has provided an opportunity for repurposing of drugs, including complex, natural drugs, to meet the global need for safe and effective antiviral medicines which do not promote multidrug resistance nor inflate medical costs. The author herein describes his own repurposing of herbal tinctures, previously prepared for oncology, into a possibly synergistic, anti-COVID 41 “herb” formula of extracts derived from 36 different plants and medicinal mushrooms. A method of multi-sample in vitro testing in green monkey kidney vero cells is proposed for testing the Hypothesis that even in such a large combination, antiviral potency may be preserved, along with therapeutic synergy, smoothness, and complexity. The possibility that the formula’s potency may improve with age is considered, along with a suitable method for testing it. Collaborative research inquiries are welcome.

Keywords
botanical
harmine
licorice
medicinal mushroom
Peganum harmala
synergen
virus
virucidal
Figures
Fig. 1.
Share
Back to top